Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Heska Corp (HSKA)
since 2014 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Heska Corp.
Table 2 shows the detailed insider transactions.
This company's CIK number is 1038133.
Total stock buying since 2014: $1,184,907.
Total stock sales since 2014: $50,566,981.
Total stock option exercises since 2014: $14,159,791.
Table 3. Detailed insider trading at Heska Corp (HSKA)
Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
2022-12-22 | Wilson Kevin S. (CEO and President) | Buy | 3,440 | 59.62 | 205,092 |
2022-09-01 | Wisnewski Nancy (Chief Operating Officer) | Option Ex | 10,000 | 8.55 | 85,500 |
2022-03-07 | Grassman Catherine (EVP, CFO) | Option Ex | 656 | .00 | 0 |
2022-03-07 | Eyl Steven M. (EVP, CCO & Pres.scil) | Option Ex | 1,562 | .00 | 0 |
2022-03-07 | Wisnewski Nancy (Chief Operating Officer) | Option Ex | 1,562 | .00 | 0 |
2022-03-03 | Baker Eleanor F. (EVP, Managing Dir. & COO, scil) | Sale | 663 | 146.37 | 97,041 |
2022-02-17 | Sveen David E. (Director) | Option Ex | 8,571 | 33.98 | 291,285 |
2022-02-11 | Wilson Kevin S. (CEO and President) | Option Ex | 45,149 | 38.81 | 1,752,368 |
2021-11-23 | Wilson Kevin S. (CEO and President) | Buy | 1,000 | 173.00 | 173,000 |
2021-11-15 | Wilson Kevin S. (CEO and President) | Buy | 1,000 | 179.00 | 179,000 |
2021-11-02 | Wisnewski Nancy (Chief Operating Officer) | Option Ex | 10,000 | 6.90 | 69,000 |
2021-08-18 | Wisnewski Nancy (Chief Operating Officer) | Sale | 1,000 | 270.43 | 270,425 |
2021-08-17 | Larson Sharon J. (Director) | Sale | 2,000 | 266.82 | 533,650 |
2021-08-17 | Larson Sharon J. (Director) | Option Ex | 2,000 | 28.41 | 56,820 |
2021-08-06 | Grassman Catherine (EVP, CFO) | Sale | 5,000 | 261.55 | 1,307,725 |
2021-08-06 | Grassman Catherine (EVP, CFO) | Option Ex | 5,000 | 69.77 | 348,850 |
2021-05-24 | Larson Sharon J. (Director) | Sale | 3,000 | 205.00 | 615,000 |
2021-05-24 | Larson Sharon J. (Director) | Option Ex | 3,000 | 28.41 | 85,230 |
2021-04-30 | Wisnewski Nancy (Chief Operating Officer) | Option Ex | 7,500 | 6.76 | 50,700 |
2021-03-07 | Grassman Catherine (EVP, CFO) | Option Ex | 657 | .00 | 0 |
2021-03-07 | Eyl Steven M. (EVP, CCO & Pres.scil) | Option Ex | 1,563 | .00 | 0 |
2021-03-07 | Wisnewski Nancy (Chief Operating Officer) | Option Ex | 1,563 | .00 | 0 |
2021-01-14 | Wilson Kevin S. (CEO and President) | Option Ex | 5,625 | .00 | 0 |
2020-12-28 | Wisnewski Nancy (Chief Operating Officer) | Option Ex | 6,000 | 4.96 | 29,760 |
2020-12-09 | Wisnewski Nancy (Chief Operating Officer) | Sale | 500 | 140.42 | 70,210 |
2020-12-08 | Wisnewski Nancy (Chief Operating Officer) | Sale | 350 | 133.16 | 46,604 |
2020-12-07 | Wisnewski Nancy (Chief Operating Officer) | Sale | 150 | 131.00 | 19,650 |
2020-12-01 | Wilson Kevin S. (CEO and President) | Option Ex | 5,625 | .00 | 0 |
2020-11-27 | Aroesty Jason D (EVP, International Diagnostics) | Sale | 13,334 | 127.06 | 1,694,218 |
2020-11-27 | Aroesty Jason D (EVP, International Diagnostics) | Option Ex | 13,334 | 106.67 | 1,422,337 |
2020-11-18 | Wisnewski Nancy (Chief Operating Officer) | Sale | 500 | 129.50 | 64,750 |
2020-11-16 | Wisnewski Nancy (Chief Operating Officer) | Sale | 1,000 | 126.50 | 126,500 |
2020-11-09 | Trowbridge Bonnie J. (Director) | Sale | 4,917 | 127.36 | 626,248 |
2020-11-09 | Trowbridge Bonnie J. (Director) | Option Ex | 4,917 | 28.96 | 142,396 |
2020-11-03 | Wilson Kevin S. (CEO and President) | Option Ex | 5,625 | .00 | 0 |
2020-10-21 | Wilson Kevin S. (CEO and President) | Sale | 13,421 | 110.00 | 1,476,310 |
2020-10-08 | Wilson Kevin S. (CEO and President) | Sale | 3,129 | 109.00 | 341,061 |
2020-08-31 | Wisnewski Nancy (Chief Operating Officer) | Sale | 1,050 | 103.83 | 109,024 |
2020-08-05 | Wilson Kevin S. (CEO and President) | Sale | 9,176 | 108.00 | 991,008 |
2020-06-05 | Wilson Kevin S. (CEO and President) | Sale | 10,000 | 91.00 | 910,000 |
2020-06-03 | Wilson Kevin S. (CEO and President) | Sale | 9,707 | 89.00 | 863,923 |
2020-05-28 | Wilson Kevin S. (CEO and President) | Sale | 6,234 | 88.00 | 548,592 |
2020-05-27 | Wilson Kevin S. (CEO and President) | Sale | 6,059 | 86.50 | 524,103 |
2020-05-26 | Wilson Kevin S. (CEO and President) | Sale | 3,266 | 85.00 | 277,610 |
2020-05-19 | Wilson Kevin S. (CEO and President) | Sale | 1,734 | 85.00 | 147,390 |
2020-03-07 | Grassman Catherine (EVP, CFO) | Option Ex | 657 | .00 | 0 |
2020-03-07 | Eyl Steven M. (EVP, Global Sales & Marketing) | Option Ex | 1,563 | .00 | 0 |
2020-03-07 | Wisnewski Nancy (Chief Operating Officer) | Option Ex | 1,563 | .00 | 0 |
2019-12-30 | Napolitano Jason A (Chief Strategy Officer) | Option Ex | 147 | 39.76 | 5,844 |
2019-12-23 | Napolitano Jason A (Chief Strategy Officer) | Option Ex | 146 | 39.76 | 5,804 |
2019-05-30 | Humphrey Scott (Director) | Buy | 1,000 | 73.79 | 73,790 |
2019-05-13 | Wisnewski Nancy (EVP, Diag. Ops & Prod. Dev.) | Option Ex | 7,000 | 4.75 | 33,250 |
2019-02-19 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Option Ex | 10,000 | 8.55 | 85,500 |
2019-02-14 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Sale | 7,500 | 97.83 | 733,687 |
2019-02-13 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Option Ex | 19,498 | 7.36 | 143,505 |
2019-02-12 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Option Ex | 9,390 | 18.13 | 170,240 |
2019-02-11 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Option Ex | 5,500 | 8.38 | 46,090 |
2019-02-08 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Option Ex | 146 | 39.76 | 5,804 |
2019-02-06 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Option Ex | 1,265 | 98.20 | 124,223 |
2019-02-05 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Option Ex | 502 | 7.36 | 3,694 |
2019-02-04 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Sale | 7,500 | 100.00 | 750,000 |
2019-02-01 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Option Ex | 10,000 | 6.90 | 69,000 |
2019-01-31 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Option Ex | 13,500 | 4.96 | 66,960 |
2019-01-30 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Option Ex | 14,000 | 4.50 | 63,000 |
2019-01-29 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Option Ex | 7,812 | 72.85 | 569,104 |
2019-01-28 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Option Ex | 2,901 | 32.21 | 93,441 |
2019-01-25 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Sale | 7,500 | 95.53 | 716,482 |
2019-01-25 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Option Ex | 4,610 | 18.13 | 83,579 |
2019-01-18 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Option Ex | 14,250 | 39.76 | 566,580 |
2019-01-17 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Sale | 2,671 | 90.23 | 240,998 |
2019-01-16 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Sale | 4,829 | 90.86 | 438,753 |
2018-12-03 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Sale | 1,210 | 104.41 | 126,336 |
2018-11-30 | Wilson Kevin S. (CEO and President) | Sale | 1,631 | 104.50 | 170,439 |
2018-11-30 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Sale | 1,790 | 104.00 | 186,160 |
2018-11-29 | Gordon G Irwin (Director) | Sale | 4,000 | 102.00 | 408,000 |
2018-11-28 | Wilson Kevin S. (CEO and President) | Sale | 181 | 104.00 | 18,824 |
2018-11-21 | Gordon G Irwin (Director) | Sale | 6,700 | 98.24 | 658,194 |
2018-11-09 | Wilson Kevin S. (CEO and President) | Sale | 3,190 | 104.07 | 331,992 |
2018-11-05 | Gordon G Irwin (Director) | Option Ex | 23,571 | 20.04 | 472,268 |
2018-11-01 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Option Ex | 11,000 | 4.40 | 48,400 |
2018-10-12 | Wisnewski Nancy (EVP, Diag. Ops & Prod. Dev.) | Option Ex | 5,000 | 4.40 | 22,000 |
2018-09-13 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Sale | 2,500 | 111.50 | 278,750 |
2018-08-31 | Lippincott Rod (EVP, Comp. Animal Health Sales) | Sale | 6,371 | 104.00 | 662,584 |
2018-08-31 | Lippincott Rod (EVP, Comp. Animal Health Sales) | Option Ex | 6,371 | 43.58 | 277,648 |
2018-08-28 | Asakowicz Steve (EVP, Comp. Animal Health Sales) | Sale | 6,800 | 101.11 | 687,514 |
2018-08-28 | Asakowicz Steve (EVP, Comp. Animal Health Sales) | Option Ex | 6,800 | 43.58 | 296,344 |
2018-08-27 | Asakowicz Steve (EVP, Comp. Animal Health Sales) | Sale | 1,200 | 101.02 | 121,224 |
2018-08-27 | Asakowicz Steve (EVP, Comp. Animal Health Sales) | Option Ex | 1,200 | 18.13 | 21,756 |
2018-08-24 | Lippincott Rod (EVP, Comp. Animal Health Sales) | Sale | 300 | 104.00 | 31,200 |
2018-08-24 | Lippincott Rod (EVP, Comp. Animal Health Sales) | Option Ex | 300 | 18.13 | 5,439 |
2018-08-23 | Lippincott Rod (EVP, Comp. Animal Health Sales) | Sale | 2,505 | 104.03 | 260,605 |
2018-08-23 | Lippincott Rod (EVP, Comp. Animal Health Sales) | Option Ex | 2,505 | 18.13 | 45,415 |
2018-08-13 | Eyl Steven M. (EVP, Global Sales & Marketing) | Sale | 7,378 | 98.00 | 723,044 |
2018-08-13 | Eyl Steven M. (EVP, Global Sales & Marketing) | Option Ex | 7,378 | 56.30 | 415,418 |
2018-08-10 | Eyl Steven M. (EVP, Global Sales & Marketing) | Sale | 1,051 | 98.00 | 102,998 |
2018-08-10 | Eyl Steven M. (EVP, Global Sales & Marketing) | Option Ex | 1,051 | 39.76 | 41,787 |
2018-08-09 | Eyl Steven M. (EVP, Global Sales & Marketing) | Sale | 24,922 | 99.19 | 2,471,963 |
2018-08-09 | Eyl Steven M. (EVP, Global Sales & Marketing) | Option Ex | 24,922 | 22.65 | 564,582 |
2018-07-09 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Sale | 1,200 | 110.00 | 132,000 |
2018-06-08 | Wisnewski Nancy (EVP, Diag. Ops & Prod. Dev.) | Sale | 750 | 106.50 | 79,875 |
2018-06-08 | Gordon G Irwin (Director) | Sale | 3,400 | 106.00 | 360,400 |
2018-06-07 | Gordon G Irwin (Director) | Sale | 3,400 | 103.86 | 353,124 |
2018-06-06 | Gordon G Irwin (Director) | Sale | 3,400 | 105.47 | 358,611 |
2018-06-05 | Gordon G Irwin (Director) | Sale | 3,400 | 105.64 | 359,162 |
2018-06-04 | Gordon G Irwin (Director) | Sale | 3,400 | 105.74 | 359,516 |
2018-06-01 | Wisnewski Nancy (EVP, Diag. Ops & Prod. Dev.) | Sale | 2,250 | 108.20 | 243,456 |
2018-06-01 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Sale | 2,500 | 108.50 | 271,250 |
2018-05-31 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Sale | 3,633 | 107.15 | 389,275 |
2018-05-30 | Wisnewski Nancy (EVP, Diag. Ops & Prod. Dev.) | Sale | 1,200 | 105.56 | 126,674 |
2018-05-30 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Sale | 2,869 | 105.30 | 302,105 |
2018-05-29 | Trowbridge Bonnie J. (Director) | Sale | 5,000 | 100.78 | 503,900 |
2018-05-29 | Trowbridge Bonnie J. (Director) | Option Ex | 5,000 | 28.41 | 142,050 |
2018-05-29 | Wisnewski Nancy (EVP, Diag. Ops & Prod. Dev.) | Sale | 1,300 | 102.86 | 133,718 |
2018-05-18 | Eyl Steven M. (EVP, Global Sales & Marketing) | Sale | 582 | 103.00 | 59,946 |
2017-12-28 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Option Ex | 11,000 | 18.30 | 201,300 |
2017-12-13 | Wisnewski Nancy (EVP, Diag. Ops & Prod. Dev.) | Option Ex | 7,000 | 18.30 | 128,100 |
2017-11-30 | Mcginley Michael J (Presi, Biologic. & Pharm.) | Sale | 6,500 | 86.02 | 559,123 |
2017-11-29 | Mcginley Michael J (Presi, Biologic. & Pharm.) | Sale | 7,025 | 87.02 | 611,280 |
2017-11-28 | Mcginley Michael J (Presi, Biologic. & Pharm.) | Sale | 800 | 88.19 | 70,548 |
2017-11-27 | Mcginley Michael J (Presi, Biologic. & Pharm.) | Sale | 1 | 88.54 | 88 |
2017-08-31 | Wisnewski Nancy (EVP, Diag. Ops & Prod. Dev.) | Sale | 825 | 102.21 | 84,326 |
2017-08-30 | Mcmahon John (VP, Chief Financial Officer) | Sale | 2,608 | 101.15 | 263,804 |
2017-08-30 | Mcmahon John (VP, Chief Financial Officer) | Option Ex | 2,608 | 53.46 | 139,431 |
2017-06-01 | Asakowicz Steve (EVP, Comp. Animal Health Sales) | Sale | 382 | 100.06 | 38,224 |
2017-06-01 | Asakowicz Steve (EVP, Comp. Animal Health Sales) | Option Ex | 382 | 18.13 | 6,925 |
2017-05-31 | Lippincott Rod (EVP, Comp. Animal Health Sales) | Sale | 4,471 | 98.00 | 438,158 |
2017-05-31 | Lippincott Rod (EVP, Comp. Animal Health Sales) | Option Ex | 4,471 | 50.79 | 227,082 |
2017-05-31 | Mcginley Michael J (Presi, Biologic. & Pharm.) | Sale | 11,189 | 98.53 | 1,102,429 |
2017-05-26 | Lippincott Rod (EVP, Comp. Animal Health Sales) | Sale | 6,756 | 98.03 | 662,256 |
2017-05-26 | Lippincott Rod (EVP, Comp. Animal Health Sales) | Option Ex | 6,756 | 21.91 | 148,057 |
2017-05-24 | Wisnewski Nancy (EVP, Diag. Ops & Prod. Dev.) | Sale | 250 | 100.17 | 25,042 |
2017-05-24 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Sale | 5,000 | 100.50 | 502,500 |
2017-05-23 | Mcmahon John (VP, Chief Financial Officer) | Sale | 587 | 97.00 | 56,937 |
2017-05-23 | Mcmahon John (VP, Chief Financial Officer) | Option Ex | 417 | 34.08 | 14,209 |
2017-05-23 | Wrenn Carol (Director) | Sale | 1,630 | 96.97 | 158,056 |
2017-05-23 | Wrenn Carol (Director) | Option Ex | 1,630 | 8.10 | 13,203 |
2017-05-04 | Larson Sharon J. (Director) | Buy | 1,000 | 90.00 | 90,000 |
2017-05-01 | Gordon G Irwin (Director) | Option Ex | 19,016 | 13.39 | 254,624 |
2017-04-11 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Sale | 200 | 100.73 | 20,146 |
2017-04-10 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Sale | 4,800 | 103.19 | 494,399 |
2017-03-09 | Lippincott Rod (EVP, Comp. Animal Health Sales) | Sale | 5,157 | 97.87 | 504,720 |
2017-03-09 | Lippincott Rod (EVP, Comp. Animal Health Sales) | Option Ex | 5,157 | 11.28 | 58,170 |
2017-03-09 | Mcmahon John (VP, Chief Financial Officer) | Sale | 708 | 97.42 | 68,973 |
2017-03-09 | Mcmahon John (VP, Chief Financial Officer) | Option Ex | 708 | 34.08 | 24,125 |
2017-03-09 | Wisnewski Nancy (EVP, Diag. Ops & Prod. Dev.) | Sale | 500 | 96.64 | 48,321 |
2017-03-06 | Wilson Kevin S. (CEO and President) | Sale | 8,000 | 90.00 | 720,000 |
2017-03-02 | Eyl Steven M. (EVP, Global Sales & Marketing) | Sale | 10,000 | 89.25 | 892,550 |
2017-03-02 | Eyl Steven M. (EVP, Global Sales & Marketing) | Option Ex | 10,000 | 7.36 | 73,600 |
2017-01-10 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Sale | 5,000 | 74.69 | 373,450 |
2016-11-29 | Gordon G Irwin (Director) | Sale | 70 | 67.70 | 4,739 |
Insider trading activities including stock purchases, stock sales, and option exercises
of HSKA listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Heska Corp (symbol HSKA,
CIK number 1038133) see
the Securities and Exchange Commission (SEC) website.